Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Sands Capital Management, LLC's stake in Ultragenyx Pharmaceutical Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Sands Capital Management, LLC's stake in Ultragenyx Pharmaceutical Inc. fell to 4.70%, 4,298,003 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 4,298,003
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SANDS CAPITAL MANAGEMENT, LLC | 4.70% | 4,298,003 |
| SANDS FRANK M. | 4.70% | 4,298,003 |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Sands Capital Management, LLC
- Ultragenyx Pharmaceutical Inc. shareholders
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026